{"url_path":"/fda/drug/recalls/D-0705-2026","section_key":"summary","section_title":"DRUG Recall: Major Pharmaceuticals — Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA.  NDC: 0904-6955-61","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-07-13","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0705-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Major Pharmaceuticals"},"word_count":76,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0705-2026\n\n**Recalling firm:** Major Pharmaceuticals\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-07-13\n**Report date:** 2026-07-29\n\n## Product\nLevothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA.  NDC: 0904-6955-61\n\n## Reason\nSubpotent Drug\n\n## Affected lots\nLot #: N02266, Exp. Date 11/2026\n\n## Distribution\nNationwide in the USA."}